Literature DB >> 4305163

Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.

A F Habeeb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4305163     DOI: 10.1016/0003-9861(69)90055-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  11 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

2.  Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation.

Authors:  R W Worthington; M S Mülders
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Purification and biochemical properties of Clostridium perfringens type A enterotoxin.

Authors:  R L Stark; C L Duncan
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

4.  Solid-phase radioimmunoassays for quantitative antibody determination of Clostridium perfringens type D epsilon toxin.

Authors:  S Bernáth
Journal:  Appl Microbiol       Date:  1975-10

5.  Anti-idiotypic antibody-induced protection against Clostridium perfringens type D.

Authors:  D A Percival; A D Shuttleworth; E D Williamson; D C Kelly
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

6.  Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model.

Authors:  Sameera Sayeed; M E Fernandez-Miyakawa; Derek J Fisher; Vicki Adams; Rachael Poon; Julian I Rood; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

7.  Tryptophan content of Clostridium perfringens epsilon toxin.

Authors:  J Sakurai; M Nagahama
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

8.  Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.

Authors:  J Sakurai; M Nagahama; Y Fujii
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.

Authors:  Susan L Robertson; Jihong Li; Francisco A Uzal; Bruce A McClane
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

10.  Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents.

Authors:  John C Freedman; Jihong Li; Francisco A Uzal; Bruce A McClane
Journal:  mBio       Date:  2014-10-21       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.